Cancer incidence in patients with type 2 diabetes using sulphonylureas

DOI

A prospective cohort study investigating the association between using sulphonylureas (a class of oral blood glucose lowering drugs) and the incidence of (obesity-related) cancer.

Date Submitted: 2020-01-27

Identifier
DOI https://doi.org/10.17026/DANS-Z42-GF55
Metadata Access https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/DANS-Z42-GF55
Provenance
Creator GWD Landman
Publisher DANS Data Station Life Sciences
Contributor N. Kleefstra; N Kleefstra
Publication Year 2020
Rights DANS Licence; info:eu-repo/semantics/restrictedAccess; https://doi.org/10.17026/fp39-0x58
OpenAccess false
Contact N. Kleefstra (Langerhans Medical Research Institute)
Representation
Resource Type Dataset
Format application/zip; text/xml
Size 12190; 4146050
Version 1.0
Discipline Life Sciences; Medicine